5,0
12 mag 2020
Dipendente anonimo
Dipendente attuale, più di un anno
Cambridge, MA
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Recently part of BioNTech via acquisition of Neon Therapeutics. Signs all point to this being the best case scenario. We now have the small biotech feel of Cambridge while also being part of a larger global biotech ecosystem. Innovative & diversified portfolio that I am excited to be a part of. Lots of opportunities to learn new ways to do science. Culture and employee experience has been fantastic. Great opportunity to be a part of a company poised for huge success.
Svantaggi
Growing pains are natural. Organizational structure is largely flat which can be great as we’re all empowered but can be difficult and disorganized at times. It’s likely we need to implement more layers.